<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>GIT & Endocrine Pharmacology - Pharmacology Study Guide</title>
    
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <link rel="stylesheet" href="styles/main.css">
</head>
<body>
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <div class="reading-progress-container">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <div class="page-wrapper">
        <div class="container">
            <article class="document-article">
                <header class="document-header">
                    <div class="header-badge">
                        <span>üíä</span>
                        <span>Topic 05</span>
                    </div>
                    <h1 class="document-title">Gastrointestinal & Endocrine Systems</h1>
                    <div class="title-meta">
                        <div class="meta-item">
                            <span>üìö</span>
                            <span>Peptic Ulcers, Motility, & Diabetes</span>
                        </div>
                        <div class="meta-item">
                            <span>‚è±Ô∏è</span>
                            <span>60 min read</span>
                        </div>
                    </div>
                </header>

                <main id="main-content" class="content-wrapper">
                    <!-- Section 1: Peptic Ulcer Disease -->
                    <section class="content-section" id="pud">
                        <div class="section-header">
                            <div class="section-number">01</div>
                            <h2 class="section-title">
                                <span class="title-icon">üî•</span>
                                Peptic Ulcer Disease (PUD)
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Treatment aims to relieve symptoms, induce healing, prevent complications, and stop recurrence. Agents include acid suppressors, mucosal protectants, and antibiotics for <em>H. pylori</em>.</p>
                            
                            <h3>1. Acid Secretion Inhibitors</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <div class="list-marker"></div>
                                    <div class="list-content">
                                        <strong>H2 Receptor Antagonists:</strong> Cimetidine, Ranitidine, Famotidine.
                                        <br><em>Mechanism:</em> Selectively block H2 receptors in parietal cells.
                                        <br><em>Notes:</em> <strong>Cimetidine</strong> inhibits CYP enzymes (increases levels of warfarin, phenytoin, theophylline) and has anti-androgenic effects (impotence, gynecomastia). Ranitidine has fewer interactions.
                                    </div>
                                </li>
                                <li class="list-item">
                                    <div class="list-marker"></div>
                                    <div class="list-content">
                                        <strong>Proton Pump Inhibitors (PPIs):</strong> Omeprazole, Lansoprazole, Esomeprazole, Pantoprazole.
                                        <br><em>Mechanism:</em> Irreversibly inhibit H+/K+ ATPase (proton pump). Most effective.
                                        <br><em>Adverse Effects:</em> Increased risk of pneumonia (decreased gastric acidity), bone loss/osteoporosis with long-term use.
                                        <br><em>Interaction:</em> Omeprazole can increase Digoxin levels and decrease absorption of Ketoconazole.
                                    </div>
                                </li>
                                <li class="list-item">
                                    <div class="list-marker"></div>
                                    <div class="list-content">
                                        <strong>Anticholinergics:</strong> Pirenzepine (Selective M1 blocker). Reduces acid secretion by 40-50%.
                                    </div>
                                </li>
                            </ul>

                            <h3>2. Mucosal Protective Agents</h3>
                            <ul>
                                <li><strong>Sucralfate (Carafate):</strong> Changes into a thick substance that adheres to the ulcer crater for up to 6 hours. Needs acidic environment (do not give with antacids/H2 blockers).</li>
                                <li><strong>Colloidal Bismuth Compounds:</strong> Binds to ulcer, inhibits pepsin, and has activity against <em>H. pylori</em>. Causes black tongue/stool.</li>
                                <li><strong>Prostaglandin Analogues (Misoprostol):</strong> Increases mucus/bicarbonate secretion. Indicated for <strong>NSAID-induced ulcers</strong>. <em>Contraindication:</em> Pregnancy (Category X, induces labor).</li>
                            </ul>

                            <div class="callout callout--note">
                                <div class="callout-header">
                                    <span class="callout-icon">ü¶†</span>
                                    <h4 class="callout-title">H. Pylori Eradication Regimens</h4>
                                </div>
                                <div class="callout-content">
                                    <p>Standard therapy involves combination antibiotics for 7-14 days to prevent resistance.</p>
                                    <p><strong>Triple Therapy (1-2 weeks):</strong><br>
                                    Clarithromycin + Amoxicillin (or Metronidazole) + PPI (e.g., Omeprazole)</p>
                                    <p><strong>Quadruple Therapy:</strong><br>
                                    Tetracycline + Metronidazole + Bismuth Subsalicylate + PPI</p>
                                </div>
                            </div>
                        </div>
                    </section>

                    <!-- Section 2: Anti-Emetics -->
                    <section class="content-section" id="anti-emetics">
                        <div class="section-header">
                            <div class="section-number">02</div>
                            <h2 class="section-title">
                                <span class="title-icon">ü§¢</span>
                                Anti-Emetics
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Used to suppress vomiting caused by surgery, chemotherapy, motion sickness, or pregnancy.</p>
                            
                            <div class="table-wrapper">
                                <div class="table-container">
                                    <table class="content-table">
                                        <thead>
                                            <tr>
                                                <th>Class</th>
                                                <th>Examples</th>
                                                <th>Indication & Notes</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td><strong>Prokinetics (D2 Blockers)</strong></td>
                                                <td>Metoclopramide, Domperidone</td>
                                                <td>Post-op, Chemotherapy. <em>SE:</em> Extrapyramidal symptoms (dystonia), Galactorrhea. Domperidone does not cross BBB (less SE).</td>
                                            </tr>
                                            <tr>
                                                <td><strong>5-HT3 Antagonists</strong></td>
                                                <td>Ondansetron</td>
                                                <td>Chemotherapy-induced nausea/vomiting. Very effective.</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Antimuscarinics</strong></td>
                                                <td>Scopolamine (Hyoscine)</td>
                                                <td><strong>Motion sickness</strong> prophylaxis. <em>SE:</em> Dry mouth, blurred vision.</td>
                                            </tr>
                                            <tr>
                                                <td><strong>H1 Antagonists</strong></td>
                                                <td>Promethazine, Doxylamine</td>
                                                <td>Motion sickness, Morning sickness. <em>SE:</em> Sedation.</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Adjuvants</strong></td>
                                                <td>Dexamethasone, Cannabinoids (THC)</td>
                                                <td>Chemotherapy-induced emesis refractory to other drugs. Cannabinoids cause sedation/hallucinations.</td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>
                        </div>
                    </section>

                    <!-- Section 3: Laxatives & Anti-diarrheals -->
                    <section class="content-section" id="laxatives-diarrhea">
                        <div class="section-header">
                            <div class="section-number">03</div>
                            <h2 class="section-title">
                                <span class="title-icon">üöΩ</span>
                                Laxatives & Anti-Diarrheals
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Laxatives (Promote Defecation)</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><div class="list-marker"></div><div class="list-content"><strong>Bulk-Forming:</strong> Bran, Methylcellulose. Safest (mimic dietary fiber). Take with plenty of water.</div></li>
                                <li class="list-item"><div class="list-marker"></div><div class="list-content"><strong>Osmotic:</strong> Lactulose, Magnesium salts. Hold water in the gut. Lactulose is also used in <em>hepatic encephalopathy</em> to reduce ammonia.</div></li>
                                <li class="list-item"><div class="list-marker"></div><div class="list-content"><strong>Stimulants/Irritants:</strong> Bisacodyl, Senna, Castor Oil. Stimulate peristalsis. Can cause cramping and dependence. <strong>Avoid in pregnancy</strong> (can initiate labor).</div></li>
                                <li class="list-item"><div class="list-marker"></div><div class="list-content"><strong>Stool Softeners:</strong> Docusate, Liquid Paraffin. Emulsify stool.</div></li>
                            </ul>

                            <h3>Anti-Diarrheals</h3>
                            <ul>
                                <li><strong>Antimotility (Opioids):</strong> Loperamide (Imodium), Diphenoxylate. Decrease peristalsis. <em>Contraindication:</em> Infective diarrhea (dysentery) and children &lt;4 years.</li>
                                <li><strong>Antisecretory:</strong> Racecadotril (Enkephalinase inhibitor). Reduces intestinal hypersecretion without affecting motility.</li>
                                <li><strong>Probiotics:</strong> <em>Lactobacillus</em>. Restore normal flora (useful in antibiotic-associated diarrhea).</li>
                            </ul>
                        </div>
                    </section>

                    <!-- Section 4: Diabetes Mellitus (Insulin) -->
                    <section class="content-section" id="insulin">
                        <div class="section-header">
                            <div class="section-number">04</div>
                            <h2 class="section-title">
                                <span class="title-icon">üíâ</span>
                                Diabetes: Insulin Therapy
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Insulin promotes cellular uptake of glucose, converts glucose to glycogen, and moves potassium into cells. Essential for Type 1 DM and advanced Type 2 DM.</p>
                            
                            <div class="table-wrapper">
                                <div class="table-container">
                                    <table class="content-table">
                                        <thead>
                                            <tr>
                                                <th>Type</th>
                                                <th>Examples</th>
                                                <th>Onset</th>
                                                <th>Duration</th>
                                                <th>Notes</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td><strong>Rapid-acting</strong></td>
                                                <td>Lispro, Aspart</td>
                                                <td>&lt; 15 min</td>
                                                <td>3-4 hrs</td>
                                                <td>Take immediately before eating.</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Short-acting</strong></td>
                                                <td>Regular (Novolin R)</td>
                                                <td>30-60 min</td>
                                                <td>5-7 hrs</td>
                                                <td>Only type given <strong>IV</strong> (for DKA).</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Intermediate</strong></td>
                                                <td>NPH (Humulin N)</td>
                                                <td>1-2 hrs</td>
                                                <td>18-24 hrs</td>
                                                <td>Cloudy suspension. Can mix with Regular.</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Long-acting</strong></td>
                                                <td>Glargine (Lantus)</td>
                                                <td>1 hr</td>
                                                <td>24 hrs</td>
                                                <td>Basal insulin. No peak. <strong>Do not mix</strong> with others.</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Premixed</strong></td>
                                                <td>Humulin 70/30</td>
                                                <td>30 min</td>
                                                <td>24 hrs</td>
                                                <td>Mixture of NPH (70%) and Regular (30%).</td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>

                            <div class="collapsible-section">
                                <details>
                                    <summary class="collapsible-trigger">
                                        <span class="trigger-icon">‚ñ∂</span>
                                        <strong>Adverse Effects & Interactions</strong>
                                    </summary>
                                    <div class="collapsible-content">
                                        <p><strong>Hypoglycemia:</strong> Tremors, tachycardia (sympathetic); headache, confusion (parasympathetic). <em>Tx:</em> 15g Fast sugar (conscious) or IV Dextrose/Glucagon (unconscious).</p>
                                        <p><strong>Lipohypertrophy:</strong> Fat accumulation at injection site due to repeated injections. Rotate sites.</p>
                                        <p><strong>Interactions:</strong> Beta-blockers mask hypoglycemia symptoms. Thiazides/Glucocorticoids increase blood sugar (antagonize insulin).</p>
                                    </div>
                                </details>
                            </div>
                        </div>
                    </section>

                    <!-- Section 5: Oral Hypoglycemics -->
                    <section class="content-section" id="oral-hypoglycemics">
                        <div class="section-header">
                            <div class="section-number">05</div>
                            <h2 class="section-title">
                                <span class="title-icon">üíä</span>
                                Oral Hypoglycemic Agents
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Used for Type 2 Diabetes to control blood glucose along with diet and exercise.</p>
                            
                            <h3>1. Sulfonylureas (Insulin Secretagogues)</h3>
                            <p><strong>Examples:</strong> Glibenclamide, Glipizide, Glimepiride.</p>
                            <p><strong>MOA:</strong> Stimulate pancreatic beta cells to release insulin.</p>
                            <p><strong>Risks:</strong> <strong>Hypoglycemia</strong>, weight gain. Disulfiram-like reaction with alcohol.</p>

                            <h3>2. Biguanides</h3>
                            <p><strong>Example:</strong> Metformin (Glucophage). <em>First-line therapy.</em></p>
                            <p><strong>MOA:</strong> Decreases hepatic glucose production; increases tissue sensitivity to insulin.</p>
                            <p><strong>Adverse Effects:</strong> GI distress (weight loss), Vitamin B12 deficiency. <strong>Lactic Acidosis</strong> (rare but fatal - 50% mortality). Contraindicated in renal/hepatic failure.</p>

                            <h3>3. Meglitinides</h3>
                            <p><strong>Examples:</strong> Repaglinide.</p>
                            <p><strong>MOA:</strong> Stimulate insulin release (shorter duration than sulfonylureas). Take before meals.</p>

                            <h3>4. Thiazolidinediones (Glitazones)</h3>
                            <p><strong>Examples:</strong> Rosiglitazone, Pioglitazone.</p>
                            <p><strong>MOA:</strong> Decrease insulin resistance.</p>
                            <p><strong>Risks:</strong> Fluid retention (edema), hepatotoxicity, elevated LDL.</p>

                            <h3>5. Alpha-Glucosidase Inhibitors</h3>
                            <p><strong>Example:</strong> Acarbose.</p>
                            <p><strong>MOA:</strong> Slows carbohydrate digestion/absorption in the gut.</p>
                            <p><strong>SE:</strong> GI effects (gas, cramping, diarrhea). Risk of hepatotoxicity with long-term use.</p>

                            <h3>6. Gliptins (DPP-4 Inhibitors)</h3>
                            <p><strong>Example:</strong> Sitagliptin.</p>
                            <p><strong>MOA:</strong> Augments incretin hormones to promote insulin release. Well tolerated.</p>
                            
                            <div class="callout callout--warning">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ö†Ô∏è</span>
                                    <h4 class="callout-title">Pregnancy Considerations</h4>
                                </div>
                                <div class="callout-content">
                                    <p>Most oral agents are <strong>Pregnancy Category C</strong> or generally avoided in favor of Insulin during pregnancy. Metformin and Acarbose are Category B.</p>
                                </div>
                            </div>
                        </div>
                    </section>
                </main>

                <nav class="document-nav">
                    <div class="nav-container">
                        <a href="topic-04-cardiovascular-respiratory.html" class="nav-button nav-button--large nav-button--previous">
                            <div class="nav-label">Previous</div>
                            <div class="nav-title">CVS & Respiratory</div>
                        </a>
                        
                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span>05</span>
                                <span class="progress-separator">/</span>
                                <span>05</span>
                            </div>
                            <div class="progress-bar-container">
                                <div class="progress-bar-fill" style="width: 100%;"></div>
                            </div>
                            <div class="progress-label">Module Complete</div>
                        </div>
                        
                        <a href="index.html" class="nav-button nav-button--large nav-button--next">
                            <div class="nav-label">Finish</div>
                            <div class="nav-title">Back to Index</div>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

    <script src="js/theme.js"></script>
    <script>
        const progressBar = document.getElementById('reading-progress');
        function updateReadingProgress() {
            const scrollTop = window.pageYOffset || document.documentElement.scrollTop;
            const scrollHeight = document.documentElement.scrollHeight - document.documentElement.clientHeight;
            const scrollPercent = (scrollTop / scrollHeight) * 100;
            progressBar.style.width = Math.min(scrollPercent, 100) + '%';
        }
        window.addEventListener('scroll', updateReadingProgress);
    </script>
</body>
</html>